Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talampanel for Levodopa-Induced Dyskinesias in Parkinson's Disease
NCT00108667Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of talampanel in Parkinson's disease (PD), sponsored by National Institute of Neurological Disorders and Stroke. Started Apr 2005; status: completed.
02
Drugs
talampanel
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00108667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108667.